Bliss GVS fixes July 8 record date for ₹1 dividend
Bliss GVS Pharma Limited has announced July 8, 2026, as the record date for a ₹1.00 per share final dividend for FY2025-26, subject to approval at the 41st AGM on July 15, 2026. The AGM will be held via video conferencing, with remote e-voting available from July 12 to July 14. Book closure is from July 9 to July 15, 2026.

*this image is generated using AI for illustrative purposes only.
Bliss GVS Pharma Limited has fixed Wednesday, July 08, 2026, as the record date to determine shareholder entitlement for the final dividend for the financial year ended March 31, 2026. The Board of Directors has recommended a dividend of ₹1.00 per equity share, subject to shareholder approval at the 41st Annual General Meeting. If approved, the payment will be made on or before Friday, August 14, 2026.
The Register of Members and Share Transfer Books will remain closed from Thursday, July 09, 2026, to Wednesday, July 15, 2026, for the 41st Annual General Meeting and dividend payment. The company stated that tax will be deducted at source (TDS) on the dividend payment. For resident shareholders, TDS will be deducted at 10% if PAN is registered, or 20% if not. No tax will be deducted if the total dividend does not exceed ₹5,000.
Key AGM and Dividend Dates
| Event | Date |
|---|---|
| Record Date | Wednesday, July 08, 2026 |
| Book Closure Start | Thursday, July 09, 2026 |
| Book Closure End | Wednesday, July 15, 2026 |
| AGM Date | Wednesday, July 15, 2026 |
| Dividend Payment | On or before Friday, August 14, 2026 |
The 41st Annual General Meeting is scheduled to be held on Wednesday, July 15, 2026, at 11:00 AM through Video Conferencing or Other Audio-Visual Means. The agenda includes the adoption of financial statements for FY2025-26, the declaration of the final dividend, and the re-appointment of Mr. Narsimha Shibroor Kamath as Managing Director & CEO.
E-Voting and Participation Details
Remote e-voting facilities are available for shareholders. The e-voting period commences at 9:00 AM on Sunday, July 12, 2026, and concludes at 5:00 PM on Tuesday, July 14, 2026. Shareholders eligible to vote as on the cut-off date of Wednesday, July 08, 2026, may cast their votes electronically during this period or via e-voting during the meeting. The facility is available to at least 1,000 members on a first-come, first-served basis, excluding large shareholders and promoters.
Non-resident shareholders and other entities must submit relevant documents, such as Tax Residency Certificates, to avail of lower treaty rates. Shareholders must submit necessary declarations like Form 15G or 15H by Wednesday, July 08, 2026, to avoid higher deduction.
Historical Stock Returns for Bliss GVS Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.86% | -1.56% | +14.88% | +193.42% | +227.36% | +349.44% |
What is the expected shareholder turnout for the upcoming AGM, and how might it influence the approval of the proposed dividend?
How will the re-appointment of Mr. Narsimha Shibroor Kamath as Managing Director & CEO impact the company's strategic direction?
What are Bliss GVS Pharma's growth plans for the upcoming financial year, and how might they affect future dividend policies?































